302 related articles for article (PubMed ID: 29321768)
1. Repurposing and Revival of the Drugs: A New Approach to Combat the Drug Resistant Tuberculosis.
Sharma D; Dhuriya YK; Deo N; Bisht D
Front Microbiol; 2017; 8():2452. PubMed ID: 29321768
[TBL] [Abstract][Full Text] [Related]
2. Plan to combat extensively drug-resistant tuberculosis: recommendations of the Federal Tuberculosis Task Force.
Centers for Disease Control and Prevention (CDC)
MMWR Recomm Rep; 2009 Feb; 58(RR-3):1-43. PubMed ID: 19214162
[TBL] [Abstract][Full Text] [Related]
3. Emergence of new forms of totally drug-resistant tuberculosis bacilli: super extensively drug-resistant tuberculosis or totally drug-resistant strains in iran.
Velayati AA; Masjedi MR; Farnia P; Tabarsi P; Ghanavi J; ZiaZarifi AH; Hoffner SE
Chest; 2009 Aug; 136(2):420-425. PubMed ID: 19349380
[TBL] [Abstract][Full Text] [Related]
4. Totally drug-resistant tuberculosis and adjunct therapies.
Parida SK; Axelsson-Robertson R; Rao MV; Singh N; Master I; Lutckii A; Keshavjee S; Andersson J; Zumla A; Maeurer M
J Intern Med; 2015 Apr; 277(4):388-405. PubMed ID: 24809736
[TBL] [Abstract][Full Text] [Related]
5. Treatment of Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis in Children: The Role of Bedaquiline and Delamanid.
Pecora F; Dal Canto G; Veronese P; Esposito S
Microorganisms; 2021 May; 9(5):. PubMed ID: 34067732
[TBL] [Abstract][Full Text] [Related]
6. Clinical management of adults and children with multidrug-resistant and extensively drug-resistant tuberculosis.
Dheda K; Chang KC; Guglielmetti L; Furin J; Schaaf HS; Chesov D; Esmail A; Lange C
Clin Microbiol Infect; 2017 Mar; 23(3):131-140. PubMed ID: 27756712
[TBL] [Abstract][Full Text] [Related]
7. In vitro interaction profiles of the new antitubercular drugs bedaquiline and delamanid with moxifloxacin against clinical Mycobacterium tuberculosis isolates.
Chandramohan Y; Padmanaban V; Bethunaickan R; Tripathy S; Swaminathan S; Ranganathan UD
J Glob Antimicrob Resist; 2019 Dec; 19():348-353. PubMed ID: 31226332
[TBL] [Abstract][Full Text] [Related]
8. Delamanid, Bedaquiline, and Linezolid Minimum Inhibitory Concentration Distributions and Resistance-related Gene Mutations in Multidrug-resistant and Extensively Drug-resistant Tuberculosis in Korea.
Yang JS; Kim KJ; Choi H; Lee SH
Ann Lab Med; 2018 Nov; 38(6):563-568. PubMed ID: 30027700
[TBL] [Abstract][Full Text] [Related]
9. Overview of drug-resistant tuberculosis worldwide.
Velayati AA; Farnia P; Farahbod AM
Int J Mycobacteriol; 2016 Dec; 5 Suppl 1():S161. PubMed ID: 28043527
[TBL] [Abstract][Full Text] [Related]
10. Delamanid: From discovery to its use for pulmonary multidrug-resistant tuberculosis (MDR-TB).
Liu Y; Matsumoto M; Ishida H; Ohguro K; Yoshitake M; Gupta R; Geiter L; Hafkin J
Tuberculosis (Edinb); 2018 Jul; 111():20-30. PubMed ID: 30029909
[TBL] [Abstract][Full Text] [Related]
11. Multidrug and extensively drug-resistant tuberculosis.
Maitre T; Aubry A; Jarlier V; Robert J; Veziris N;
Med Mal Infect; 2017 Feb; 47(1):3-10. PubMed ID: 27637852
[TBL] [Abstract][Full Text] [Related]
12. Drug development against tuberculosis: Past, present and future.
Vasava MS; Bhoi MN; Rathwa SK; Borad MA; Nair SG; Patel HD
Indian J Tuberc; 2017 Oct; 64(4):252-275. PubMed ID: 28941848
[TBL] [Abstract][Full Text] [Related]
13. Repurposing Immunomodulatory Drugs to Combat Tuberculosis.
Fatima S; Bhaskar A; Dwivedi VP
Front Immunol; 2021; 12():645485. PubMed ID: 33927718
[TBL] [Abstract][Full Text] [Related]
14. Thioridazine: an old neuroleptic effective against totally drug resistant tuberculosis.
Amaral L
Acta Med Port; 2012; 25(2):118-21. PubMed ID: 22985923
[TBL] [Abstract][Full Text] [Related]
15. Recent controversies about MDR and XDR-TB: Global implementation of the WHO shorter MDR-TB regimen and bedaquiline for all with MDR-TB?
Dheda K; Cox H; Esmail A; Wasserman S; Chang KC; Lange C
Respirology; 2018 Jan; 23(1):36-45. PubMed ID: 28850767
[TBL] [Abstract][Full Text] [Related]
16. Bedaquiline: A novel drug to combat multiple drug-resistant tuberculosis.
Goel D
J Pharmacol Pharmacother; 2014 Jan; 5(1):76-8. PubMed ID: 24554919
[TBL] [Abstract][Full Text] [Related]
17. Delamanid and bedaquiline to treat multidrug-resistant and extensively drug-resistant tuberculosis in children: a systematic review.
D'Ambrosio L; Centis R; Tiberi S; Tadolini M; Dalcolmo M; Rendon A; Esposito S; Migliori GB
J Thorac Dis; 2017 Jul; 9(7):2093-2101. PubMed ID: 28840010
[TBL] [Abstract][Full Text] [Related]
18. Management of drug resistantTB in patients with HIV co-infection.
Pontali E; Sotgiu G; Centis R; D'Ambrosio L; Spanevello A; Migliori GB
Expert Opin Pharmacother; 2015; 16(18):2737-50. PubMed ID: 26478945
[TBL] [Abstract][Full Text] [Related]
19.
Pang Y; Zong Z; Huo F; Jing W; Ma Y; Dong L; Li Y; Zhao L; Fu Y; Huang H
Antimicrob Agents Chemother; 2017 Oct; 61(10):. PubMed ID: 28739779
[TBL] [Abstract][Full Text] [Related]
20. The burden of pre-extensively and extensively drug-resistant tuberculosis among MDR-TB patients in the Amhara region, Ethiopia.
Shibabaw A; Gelaw B; Gebreyes W; Robinson R; Wang SH; Tessema B
PLoS One; 2020; 15(2):e0229040. PubMed ID: 32053661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
